PotM: Disulfide-Based Self-Immolative Linkers

PotM: Disulfide-Based Self-Immolative Linkers

Published on 26/01/2021

The linkage of a drug to its carrier via a disulfide-based self-immolative linker allows for the specific intracellular release of the active molecule upon glutathione reduction and linker cleavage.

The ultimate goal of intracellular drug delivery is the spatial and temporal control of payload release upon cell entry without decomposition during transit. Thus, the interest in selective activation of bioactive agents for advanced therapeutics and diagnostics, aiming to efficiently suppress background interferences and attenuate systemic toxicity, is constantly growing. Over the last years, a new tool for controlled payload transport and release was developed to overcome this barrier. Self-immolative linkers (SILs) are a class of spacers that disintegrate upon a certain trigger to release the conjugated biomolecule in a traceless manner. Typically, the desired drug is conjugated to the proximal end of the spacer, whereas the distal end, which typically initiates the decomposition, is protected, e.g. by being bound to a carrier. Upon deprotection and self-immolation, the conjugated cargo is finally released.

 

Schematic illustration of the concept of self-immolative linkers. PG = protecting group.

One powerful system relies on disulfide-based self-immolative linkers. The overall red/ox potential in the human blood is oxidative, making disulfide linkages stable during circulation. In contrast, the intracellular milieu of mammalian cells is characterized by an overall reductive potential, thus allowing to revert the disulfide bond formation. Furthermore, cytoplasm typically shows millimolar (1-10 mM) concentrations of the reductant tripeptide glutathione (GSH) in contrast to 2-10 µM in blood and other body fluids.

 

Chemical structure of the tripeptide Glutathione.

Notably, GSH has been recognized as a biomarker of tumor development. Elevated levels are reported inside tumor mass (~100-fold) and cancer cells (~sevenfold) compared to those of normal tissues and cells, respectively. This drastic discrepancy in GSH concentration renders it possible to develop GSH-responsive materials which can be selectively activated in pathological tissues. Those specifications allow for sufficient stability of the linker in the extracellular milieu but spontaneous self-immolative reaction within the cytosol upon GSH-mediated disulfide cleavage.

SILs can be mainly classified into two groups depending on the self-immolative fragmentation process either based on the quinone methide cascade (e.g. 1,6-elimination) or an intramolecular cyclization reaction. In addition, the linker’s chemical composition (e.g. disulfide ethoxycarbonyl (SSE) vs. disulfide benzyloxycarbonyl (SSB)) results in chemically tunable kinetics of the self-immolative cleavage due to different response rate towards GSH, showing higher rates for SSB-based DSILs compared to SSE-based ones. Thus, the choice of the linker allows for fine-tuning of the cleavage speed and payload release.

 

Disulfide-based self-immolative linkers either based on an intramolecular cyclization cascade or an 1,6-elimination.

Please find many different disulfide-based self-immolative linkers within our section Related Products (see below). If you cannot find your desired derivative, please contact us for a custom synthesis!

Interested in further information on linker technologies? -> Please feel free to download our new brochure on Linkerology!

 

References:

  • Self-immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol-Free Drugs; C. F. Riber; A. A. A. Smith, A. N. Zelikin; Adv Healthcare Mater 2015; 4(12): 1887-1890. https://doi.org/10.1002/adhm.201500344.
  • Labeling Carboxyl Groups of Surface-Exposed Proteins Provides an Orthogonal Approach for Cell Surface Isolation; N. E. Ozkan Kucuk, E. Sanal, E. Tan, T. Mitchison, N. Ozlu; J Proteome Res 2018; 17: 1784-1793. https://doi.org/10.1021/acs.jproteome.7b00825.
  • Development of trifunctional probes for glycoproteomic analysis; C. S. Tsai, P. Y. Liu, H. Y. Yen, T. L. Hsu, C. H. Wong; Chem. Commun. 2010; 46: 5575-7. https://doi.org/10.1039/c0cc00345j.
  • Fluorometric assay for tissue transglutaminase-mediated transamidation activity; C. Gnaccarini, W. Ben-Tahar, W. D. Lubell, J. N. Pelletier, J. W. Keillor; Bioorg Med Chem 2009; 17: 6354-9. https://doi.org/10.1016/j.bmc.2009.07.031.
  • Convenient synthesis of photoaffinity probes and evaluation of their labeling abilities; T. Kan, Y. Kita, Y. Morohashi, Y. Tominari, S. Hosoda, T. Tomita, H. Natsugari, T. Iwatsubo, T. Fukuyama; Org Lett. 2007; 9: 2055-8. https://doi.org/10.1021/ol070376i.
  • Facile synthesis toward the construction of an activity probe library for glycosidases; T. H. Shie, Y. L. Chiang, J. J. Lin, Y. K. Li, L. C. Lo; Carbohydr Res 2006; 341: 443-56. https://doi.org/10.1016/j.carres.2005.12.005.
  • A simple photo-affinity labeling protocol; H.-Y. Li, Y. Liu, K. Fang, K. Nakanishi; Chem. Comm. 1999; 365-366. https://doi.org/10.1039/a809507h.
  • Linker Technologies for Antibody-Drug Conjugates; B. Nolting; Antibody-Drug Conjugates L. Ducry 2013; 1045: 71-100. https://doi.org/10.1007/978-1-62703-541-5_5.
  • Disulfide-Based Self-Immolative Linkers and Functional Bioconjugates for Biological Applications; Z. Deng, J. Hu, S. Liu; Macromol Rapid Commun 2020; 41: e1900531. https://doi.org/10.1002/marc.201900531.
  • Reduction-Triggered Transformation of Disulfide-Containing Micelles at Chemically Tunable Rates; Z. Deng, S. Yuan, R. X. Xu, H. Liang, S. Liu; Angew. Chem. Int. Ed. 2018; 57: 8896-8900. https://doi.org/10.1002/anie.201802909.
  • Modulated Fragmentation of Proapoptotic Peptide Nanoparticles Regulates Cytotoxicity; T. Suma, J. Cui, M. Müllner, S. Fu, J. Tran, K. F. Noi, Y. Ju, F. Caruso; J. Am. Chem. Soc. 2017; 139: 4009-4018. https://doi.org/10.1021/jacs.6b1302.
  • Engineering Intracellular Delivery Nanocarriers and Nanoreactors from Oxidation-Responsive Polymersomes via Synchronized Bilayer Cross-Linking and Permeabilizing Inside Live Cells; Z. Deng, Y. Qian, Y. Yu, G. Liu, J. Hu, G. Zhang, S. Liu; J. Am. Chem. Soc. 2016; 138: 10452-10466. https://doi.org/10.1021/jacs.6b04115.
Related Products
    1. Biotin-SS-COOH
      Biotin-SS-COOH

      Nº Artículo: RL-3300.0250

      325,00 €
    2. Boc-Cystamine*HCl
      Boc-Cystamine*HCl

      Nº Artículo: BNN1063

      Starting at 90,00 €

    3. Boc-Cystamine-Suc-OH
      Boc-Cystamine-Suc-OH

      Nº Artículo: BAA2180

      Starting at 145,00 €

    4. N3-Cystamine-Suc-OSu
      N3-Cystamine-Suc-OSu

      Nº Artículo: HAA2255

      Starting at 171,00 €

    5. Boc-Cystamine
      Boc-Cystamine

      Nº Artículo: BNN1170

      Starting at 81,00 €

    6. Biotin-SS-Tyramide
      Biotin-SS-Tyramide

      Nº Artículo: LS-3570

      Starting at 350,00 €

    7. Boc-SS-COOH
      Boc-SS-COOH

      Nº Artículo: RL-2190

      Starting at 200,00 €

    8. Fmoc-SS-COOH
      Fmoc-SS-COOH

      Nº Artículo: RL-2200

      Starting at 625,00 €

    9. N3-Cystamine*HCl
      N3-Cystamine*HCl

      Nº Artículo: HNN1090

      Starting at 90,00 €

    10. Fmoc-AEDI-OH
      Fmoc-AEDI-OH

      Nº Artículo: RL-2800

      Starting at 770,00 €

    11. Boc-AEDI-OH
      Boc-AEDI-OH

      Nº Artículo: RL-2810

      Starting at 500,00 €

    12. Biotin-PEG(4)-SS-Tyramide
      Biotin-PEG(4)-SS-Tyramide

      Nº Artículo: LS-3930

      Starting at 350,00 €

    13. Tyramide-SS-amine*HCl
      Tyramide-SS-amine*HCl

      Nº Artículo: LS-3960

      Starting at 245,00 €

    14. Biotin-SS-COOH
      Biotin-SS-COOH

      Nº Artículo: RL-3300

      Starting at 325,00 €

    15. Biotin-PEG(4)-SS-COOH
      Biotin-PEG(4)-SS-COOH

      Nº Artículo: PEG8090

      Starting at 100,00 €

    16. Biotin-PEG(4)-SS-Azide
      Biotin-PEG(4)-SS-Azide

      Nº Artículo: PEG8100

      Starting at 225,00 €

    17. Biotin-PEG(4)-SS-Alkyne
      Biotin-PEG(4)-SS-Alkyne

      Nº Artículo: PEG8110

      Starting at 350,00 €

    18. Biotin-PEG(4)-SS-DBCO
      Biotin-PEG(4)-SS-DBCO

      Nº Artículo: PEG8120

      Starting at 225,00 €

    19. Fmoc-Cystamine-Suc
      Fmoc-Cystamine-Suc

      Nº Artículo: RL-3310

      Starting at 99,00 €

    20. Tyramide-SS-COOH
      Tyramide-SS-COOH

      Nº Artículo: LS-4010

      Starting at A petición

    21. Fmoc-Cystamine*HCl
      Fmoc-Cystamine*HCl

      Nº Artículo: RL-3370

      Starting at 126,00 €

    22. Biotin-cystamine*TFA
      Biotin-cystamine*TFA

      Nº Artículo: RL-3391

      Starting at 145,00 €

    23. Boc-NH-SS-OH
      Boc-NH-SS-OH

      Nº Artículo: RL-3510

      Starting at 275,00 €

    24. Boc-NH-SS-OpNC
      Boc-NH-SS-OpNC

      Nº Artículo: RL-3520

      Starting at 175,00 €

    25. Fmoc-NH-SS-OH
      Fmoc-NH-SS-OH

      Nº Artículo: RL-3530

      Starting at 275,00 €

    26. Fmoc-NH-SS-OpNC
      Fmoc-NH-SS-OpNC

      Nº Artículo: RL-3540

      Starting at 175,00 €

    27. Boc-NH-SS-Bzl-OH
      Boc-NH-SS-Bzl-OH

      Nº Artículo: RL-3560

      Starting at A petición

    28. Boc-NH-SS-Bzl-OpNC
      Boc-NH-SS-Bzl-OpNC

      Nº Artículo: RL-3570

      Starting at A petición

    29. Alkyne-SS-COOH
      Alkyne-SS-COOH

      Nº Artículo: RL-3330

      Starting at 325,00 €

    30. Azido-Pen-SS-COOH
      Azido-Pen-SS-COOH

      Nº Artículo: RL-3320

      Starting at 325,00 €

    31. Fmoc-NH-SS-Bzl-OH
      Fmoc-NH-SS-Bzl-OH

      Nº Artículo: RL-3580

      Starting at 250,00 €